Robert Ainscow Sells 25,000 Shares of ASP Isotopes (NASDAQ:ASPI) Stock

Posted by George Bondi on Sep 6th, 2026

ASP Isotopes Inc. (NASDAQ:ASPI – Get Free Report) COO Robert Ainscow sold 25,000 shares of the business’s stock in a transaction that occurred on Wednesday, September 2nd. The shares were sold at an average price of $3.90, for a total value of $97,500.00. Following the transaction, the chief operating officer owned 2,256,879 shares of the company’s stock, valued at $8,801,828.10. This trade represents a 1.10% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.

Robert Ainscow also recently made the following trade(s):

On Monday, June 8th, Robert Ainscow sold 8,438 shares of ASP Isotopes stock. The shares were sold at an average price of $7.00, for a total value of $59,066.00.

ASP Isotopes Trading Up 7.7%

Shares of NASDAQ ASPI opened at $4.20 on Friday. The company has a debt-to-equity ratio of 0.76, a quick ratio of 3.85 and a current ratio of 3.87. The business’s 50 day moving average price is $4.37 and its 200-day moving average price is $5.20. ASP Isotopes Inc. has a fifty-two week low of $3.51 and a fifty-two week high of $14.49. The company has a market cap of $643.90 million, a price-to-earnings ratio of -3.18 and a beta of 3.59.

ASP Isotopes (NASDAQ:ASPI – Get Free Report) last posted its quarterly earnings data on Friday, August 14th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.11). The business had revenue of $5.12 million for the quarter, compared to analysts’ expectations of $4.47 million. ASP Isotopes had a negative net margin of 427.98% and a negative return on equity of 64.99%.

Institutional Trading of ASP Isotopes

Institutional investors and hedge funds have recently made changes to their positions in the company. Amundi purchased a new stake in ASP Isotopes in the second quarter worth about $107,000. California State Teachers Retirement System increased its position in ASP Isotopes by 864.2% during the 2nd quarter. California State Teachers Retirement System now owns 754,131 shares of the company’s stock valued at $4,691,000 after purchasing an additional 675,919 shares during the period. AXQ Capital LP bought a new stake in shares of ASP Isotopes in the 2nd quarter valued at about $80,000. Headlands Technologies LLC raised its holdings in shares of ASP Isotopes by 219.6% in the 2nd quarter. Headlands Technologies LLC now owns 240,197 shares of the company’s stock valued at $1,494,000 after purchasing an additional 165,031 shares in the last quarter. Finally, Alyeska Investment Group L.P. lifted its position in shares of ASP Isotopes by 5.6% in the 2nd quarter. Alyeska Investment Group L.P. now owns 2,843,503 shares of the company’s stock worth $17,687,000 after purchasing an additional 151,337 shares during the period. 16.80% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

ASPI has been the topic of several recent analyst reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ASP Isotopes in a research note on Wednesday, June 24th. Wall Street Zen raised shares of ASP Isotopes from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 22nd. Two investment analysts have rated the stock with a Buy rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $13.00.

Check Out Our Latest Stock Report on ASPI

About ASP Isotopes

(Get Free Report)

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.